Ritlecitinib Shows Significant Reduction in Alopecia Areata Psychosocial Burden

While ritlecitinib (Litfulo; Pfizer) has demonstrated significant efficacy in achieving hair regrowth for patients with severe alopecia areata, new long-term data from the ALLEGRO-2b/3 trial (NCT03732807) show that its therapeutic benefit…